Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cormedix Inc. (CRMD)  
$11.14 0.09 (0.81%) as of 4:30 Tue 10/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 74,650,000
Market Cap: 831.60(M)
Last Volume: 33,837 Avg Vol: 33,580
52 Week Range: $5.86 - $16.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Co.'s primary focus is on the development of its primary product candidate, DefenCath™, for potential commercialization in the U.S. and other main markets. Co. has in-licensed the worldwide rights to develop and commercialize DefenCath and Neutrolin®. DefenCath/Neutrolin is an anti-infective solution intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis and total parenteral nutrition.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 25,000 25,000 26,500 47,061
Total Buy Value $275,500 $275,500 $290,485 $365,453
Total People Bought 1 1 2 4
Total Buy Transactions 1 1 2 6
Total Shares Sold 163,997 163,997 163,997 163,997
Total Sell Value $2,163,382 $2,163,382 $2,163,382 $2,163,382
Total People Sold 4 4 4 4
Total Sell Transactions 5 5 5 5
End Date 2025-07-31 2025-04-29 2024-10-29 2023-10-30

   
Records found: 220
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kaplan Myron Director   –       •      –    2025-10-23 4 B $11.02 $275,500 D/D 25,000 201,034 2.39     -
   Duncan Gregory Scott Director   –       •      –    2025-09-16 4 OE $8.32 $110,931 D/D 13,333 38,333     -
   Dunton Alan W Director   –       •      –    2025-09-12 4 S $13.13 $131,300 D/D (10,000) 40,250 14%     
   Dunton Alan W Director   –       •      –    2025-09-12 4 OE $3.55 $35,500 D/D 10,000 50,250     -
   Todisco Joseph Chief Executive Officer   •       –      –    2025-09-12 4 S $13.00 $650,000 D/D (50,000) 509,496 14%     
   Todisco Joseph Chief Executive Officer   •       –      –    2025-09-12 4 OE $3.47 $173,500 D/D 50,000 559,496     -
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-09-11 4 S $13.08 $537,863 D/D (41,121) 176,990 15%     
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-09-11 4 OE $1.45 $59,625 D/D 41,121 218,111     -
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-09-09 4 S $13.51 $173,955 D/D (12,876) 176,990 14%     
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-09-09 4 OE $1.45 $18,670 D/D 12,876 189,866     -
   Zelnick Kaufman Beth Chief Legal Officer   •       –      –    2025-09-09 4 S $12.82 $670,264 D/D (50,000) 180,418 14%     
   Zelnick Kaufman Beth Chief Legal Officer   •       –      –    2025-09-09 4 OE $3.30 $165,000 D/D 50,000 230,418     -
   Zelnick Kaufman Beth Chief Legal Officer   •       –      –    2025-08-29 4/A D $14.83 $131,690 D/D (8,880) 180,418     -
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-08-29 4/A D $14.83 $124,928 D/D (8,424) 176,990     -
   Blum Susan Chief Financial Officer   •       –      –    2025-08-29 4 A $0.00 $0 D/D 69,686 69,686     -
   Zelnick Kaufman Beth Chief Legal Officer   •       –      –    2025-08-29 4 A $0.00 $0 D/D 69,686 189,298     -
   Masson Elizabeth Chief Operating Officer   •       –      –    2025-08-29 4 A $0.00 $0 D/D 69,686 185,414     -
   Todisco Joseph Chief Executive Officer   •       –      –    2025-05-10 4 D $11.66 $247,484 D/D (21,225) 509,496     -
   Lefkowitz Steven W Director   –       •      –    2025-04-02 4 OE $4.03 $80,600 D/D 20,000 120,498     -
   Todisco Joseph Chief Executive Officer   •       •      –    2025-04-01 4 OE $3.38 $199,995 D/D 59,170 530,721     -
   Stewart Robert A Director   –       •      –    2025-01-17 4 A $0.00 $0 D/D 25,000 36,000     -
   Dunton Alan W Director   –       •      –    2025-01-17 4 A $0.00 $0 D/D 25,000 40,250     -
   Todisco Joseph Chief Executive Officer   •       •      –    2025-01-17 4 D $12.17 $291,800 D/D (23,977) 471,551     -
   Todisco Joseph Chief Executive Officer   •       •      –    2025-01-17 4 A $0.00 $0 D/D 187,500 495,528     -
   Duncan Gregory Scott Director   –       •      –    2025-01-17 4 A $0.00 $0 D/D 25,000 25,000     -
  220 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us